Minerva Neurosciences (NERV) Tops Q3 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.12 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• Magnificent 7 stocks lose $2.3 trillion in June
• Merck (MRK) PT Raised to $155 at Scotiabank